Small molecule api market
Small Molecule API Market - Global Forecast to 2026, by API Type (Artificial, and Natural), by Category (Analgesic, Anesthetics, Anticonvulsants, Antimetabolites, Antibacterial, Alkylating Agents, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018- 2026
- Apr 2019
- CMI2423
- 261 Pages
- Excel & Pdf
- Pharmaceutical
A Small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process, with a size on the order of 1 nm. Most of the small molecule can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach at intracellular site of action.
Small Molecule API Market – Dynamics
The small molecule API market is witnessing rapid growth due to increasing number of corporate agreements. For instance, BASF Pharma will sell its OMEGA 3 manufacturing facility in Norway to Marine Ingredients. The Highly Potent Active Pharmaceutical Ingredients (HPAPI) is projected to witness high growth rate, owing to easy access to the people for medication in emerging economies. The rising prevalence of diseases such as cancer, cardiovascular, and infectious diseases is expected to propel demand for manufacturing of small molecule APIs. According to the National Center for Biotechnology Information (NCBI) report, in 2014, out of 570,341 deaths 29.4% were due to cancer and 27.1% were due to cardiovascular disease. Increasing consumer awareness, benefits of small molecule API, expiry of patents covering the top-selling pharmaceuticals, and technological advancement in manufacturing sector are expected to drive the market growth over the forecast period. Increasing adoption of generic drugs has resulted into affordable healthcare expenditure, which is expected to increase production of small molecule API’s, in turn driving the global small molecule API market growth. According to the Indian Brand Equity Foundation (IBEF), in 2018, India is largest producer of generic medicines, which supplies 50% of vaccines and 40% of drugs to the U.S. and 25% of drugs to the U.K.
Small Molecule API Market – Regional insights
North America held the largest market share for small molecule API registering for 38.84% in 2017, due to high adoption rate of accelerated regulatory review of innovative medicines. Asia Pacific excluding Japan (APEJ) market is estimated to witness rapid growth in market, owing to high adoption of over the counter (OTC) drugs by large patient population coupled with growing healthcare and pharmaceutical industry and strong research and development in API. According to IBEF, investment in research and development by Indian pharmaceutical companies increased (in term of sales) from 5.3% to 8.5% from 2012 to 2018.
Small Molecule API Market – Competitive landscape
The major player operating in global small molecule API market include ALLERGAN, Aurobindo Pharma, Cambrex Corporation, Albemarle Corporation, D.r. Reddy’s Laboratories Ltd. The other key players in market are Johnson Matthey, Siegfried Holding AG, Pfizer, Sanofi S.A., Novartis AG, Johnson & Johnson, Bristol-Myers Squibb, Bachem Holding AG, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline PLC, GILEAD Science Inc., Albany Molecular Research Inc., Sun Pharmaceuticals, AstraZeneca, Merck & Co, Inc., BASF SE, and Teva Pharmaceuticals. In March 2012, the FDA approved Ilumya (Tildrakizumab-asmn) developed by Sun Pharmaceuticals used for Plaque Psoriasis.
Global Small Molecule API - Market Taxonomy
- On the basis of API type, the global small molecule API market is segmented into:
- Synthetic
- Biological
- On the basis of application, the global small molecule API market is segmented into:
- Oncology
- Neurology
- Metabolic
- Infectious
- Cardiovascular
- On the basis of geography, the global small molecule API market is segmented into
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By API Type
- Market Snippet, By Category
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Collaborations, Mergers and Acquisitions
- Regulatory Scenario
- Technological Advancements
- Steps to Manufacture Small Molecule API
- Major Suppliers of Small Molecule APIs
- Market Trends
- Global Small Molecule API Market, By API Type, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Artificial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Natural
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Small Molecule API Market, By Category, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017 – 2026
- Segment Trends
- Analgesic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Anesthetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Antimetabolites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Antibacterial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Alkylating Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Global Small Molecule API Market, By Region, 2018 – 2026, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By API Type, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Category, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Lonza
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi S.A.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aesica Pharmaceuticals Ltd.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Albemarle Corporation
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cambrex Corporation
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BASF SE
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Gland Pharma Limited
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Gilead Sciences, Inc.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca Plc
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- BASF SE
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter International Inc.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Celgene Corporation
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Piramal Pharma Solutions
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Recipharm AB
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evonik Industries AG
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Glenmark Pharmaceuticals Limited
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siegfried AG
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AbbVie Contract Manufacturing
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Aurinia Pharmaceuticals Inc.
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Patheon
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- CordenPharma International
- Company Overview
- API Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
*Browse 34 market data tables and 23 figures on “Small Molecule API Market - Global forecast to 2026”.